Has Stacey Lejeune, MD received payments from drug or device companies?

Yes. Drug and device makers reported $105,291 in general payments to Stacey Lejeune, MD across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stacey Lejeune, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stacey Lejeune, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stacey Lejeune, MD

Vascular Surgery · Wausau, WINPI 1114261591

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Silk Road Medical, Inc. at 42.9% of the total. Among vascular surgery clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,291in general payments, 2019–2025

Across 175 payments — averaging $601.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Silk Road Medical, Inc.$45K
Boston Scientific$24K
Johnson & Johnson$24K
Bard Peripheral Vascular, Inc.$8K
W. L. Gore & Associates, Inc.$2K
Medtronic$806
plus $527 from 8 others

What the payments were for

Consulting fees$31,17630%
Speaking & faculty fees$55,89553%
Travel & lodging$12,06411%
Food & beverage$6,0686%
Entertainment$890%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Silk Road Medical, Inc.	53	$45,209
Boston Scientific	46	$24,273
Johnson & Johnson	30	$24,235
Bard Peripheral Vascular, Inc.	7	$8,282
W. L. Gore & Associates, Inc.	12	$1,959
Medtronic(2 entities)	18	$806
Janssen Scientific Affairs, LLC	2	$144
Terumo Medical Corporation	1	$104
Stryker	1	$101
Cook Medical LLC	1	$61
BD	1	$44
Organogenesis Inc.	1	$34
Inari Medical, Inc.	1	$25
Penumbra, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENROUTE Transcarotid Neuroprotection System$85,195
ENROUTE Transcarotid Stent$44,358
XARELTO$23,912
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$21,261
CAROTID WALLSTENT$2,163
GENERAL - THERAPIES$2,161
GORE TAG Thoracic Endoprosthesis$1,649
ENHANCE Transcarotid Peripheral Access Kit$932
ENROUTE .014 Guidewire$600
Halo One Thin-Walled Guiding Sheath$586
ENROUTE Transcarotid Stent System$332
ENROUTE 0.014 Guidewire$332
ENDURANT IIS$233
Azur CX Detachable$104
GENERAL VASCULAR INTERVENTION$104
FLOWTRIEVER CATHETER, S$101
CT THROMBECTOMY SYSTEM KIT$101

How this compares

$105,291 in reported general payments places this provider in the 95th percentile of 81 vascular surgery providers in Wisconsin.

See all vascular surgery providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$252,721

Medicare patients

363

Services billed

989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	145	$1,426
Atorvastatin Calcium	51	$322
Rosuvastatin Calcium	28	$242
Gabapentin	17	$181
Methylprednisolone	11	$70
Oxycodone Hcl	19	$69

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Wausau

Benjamin HerdrichWausau$90K
Kevin SchoepelWausau$17K
Dennis CostaWausau$6K
Daniel BrownWausau$4K
Ralph FairchildWausau$3K
Dai YamanouchiMadison$78K
Tahlia WeisMarshfield$22K
Tiziano TallaritaEau Claire$15K
John RobertsonTomah$15K
Momodou JammehMilwaukee$14K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →